Lung cancer is the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 75% of lung cancers, is usually diagnosed at advanced stages and has a 5-year survival rate of <5%.
| Cell isolation
Peripheral blood mononuclear cells were isolated from blood samples using a Ficoll-Hypaque density gradient centrifugation method.
Serum samples were obtained by centrifugation at 1500 g for 10 minutes and were immediately stored at −80°C. Serum IL-21 was assessed using ELISA (eBioscience, San Diego, CA, USA). 
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| Flow cytometry analysis
The following cell surface antibodies were used: PerCP-CD3 (clone Figure   S1 ). Tfh subtypes were determined according to CXCR3 and CCR6 expression after cells were gated on CD3 + CD4 + CXCR5 + ( Figure S1 ) and the PD-1 expression of the three subtypes was further analyzed.
For the detection of intracellular cytokines following cell surface staining, cells were fixed and permeabilized using a Cytofix/ Cytoperm kit (BD Biosciences) and then stained using PE-IL-10 (clone 
| Function analyses of Tfh cells
| Enzyme-linked immunosorbent assay
Human IL-21, IL-10, TGF-β and TNF-α ELISA Ready-Set-Go Kits (eBioscience) were used to examine cytokine levels following instructions provided by the manufacturer.
| Immunohistochemistry for PD-L1
All measurements for PD-L1 were obtained according to the immunohistochemistry (IHC) protocols provided by the manufacturers.
All IHC results were checked independently by two pathologists.
The cutoff for PD-L1 expression on tumor cells (Dako, 22C3, Copenhagen, Denmark; approved by the FDA) was equal to or more than 50% staining.
| Statistical analysis
Statistical analysis was carried out with GraphPad Prism 5.01 software (GraphPad Software Inc., San Diego, CA, USA). The statistical tests used for data analysis included the Mann-Whitney U test and the
Pearson test for correlation analysis. Quantitative data are presented as the mean values ± standard deviations (SD). Differences were considered to be statistically significant at values of P < .05 and P < .01. 
| RE SULTS
| Elevated numbers of
| Decreased serum IL-21 levels and its negative association with circulating Tfh cells in NSCLC patients
Interleukin-21 is produced mainly by Tfh cells. Although the number of Tfh cells was elevated in NSCLC patients, in the present study, we observed decreased serum IL-21 levels (Figure 2A 
| High expression of PD-L1 on tumor cells is significantly correlated with high numbers of circulating Tfh cells in NSCLC patients
Non-small cell lung cancer is known to upregulate PD-L1 expression, and high PD-L1 expression is an independent predictor of poor prognosis. 23, 24 In the present study, we found that 32 NSCLC samples (56.1%) stained negative for PD-L1, and 25
NSCLC samples (43.9%) stained positive for PD-L1 ( Figure 4A,B) . Figure 4D ) and Tfh cells ( Figure 4E ), but there was no significant correlation with CD4 + CXCR5 + ( Figure 4C ) and clinicopathological factors (data not shown). As previously reported, we also found that NSCLC patients with PD-L1-negative tumor cells had longer diseasefree survival after tumor resection ( Figure 4F ).
FIGURE 3 Follicular helper T (Tfh) cells from non-small cell lung cancer (NSCLC) patients induce differentiation of regulatory B cells and
| Negative correlation between Tfh1 subtypes with disease-free survival
Thus, we determined whether Tfh cells with high PD-1 expression were also predictive of survival time in NSCLC. We analyzed the correlation between Tfh cells and disease-free survival after tumor resection. Interestingly, the number of Tfh1 subtypes Figure 5D ). However, no significant association was found between CD4 + CXCR5 + , CD4 + PD-1 + , Tfh cells, Tfh2, or Tf17 subtypes and disease-free survival of NSCLC patients ( Figure 5A ,B,C,E,F). High PD-L1 expression in NSCLC was an independent predictor of poor prognosis. 33 We found that high expression of PD-L1 in tumor cells is significantly correlated with a high number of circulating Tfh cells in NSCLC patients. NSCLC patients with PD-L1-negative tumor cells had longer disease-free survival, as reported in other studies. 23, 24 Gu-Trantien et al 25 found that when Tfh cell infiltration in breast cancer patients was greater, the prognosis of patients was better. Additionally, impaired function of Tfh cells is associated with hepatocellular carcinoma progression. 34, 35 Thus, Tfh cells are likely to be associated with prognosis of tumor. Interestingly, in the present study, we found that the number of Tfh1 subtypes was negatively correlated with disease-free survival after tumor resection, which may be related to immunosuppression induced by high PD-1 expression in Tfh1 subtypes. However, our data were based on a relatively small number of patients. For this reason, we were unable to reliably assess the predictive utility of Tfh1 subtypes on NSCLC patient survival and will expand our samples and conduct a larger study. 
| Circulating Tfh cells in NSCLC patients with different histological subtypes
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